α-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease

FEMS Yeast Research

Volumn 6, Issue 8, 2006, Pages 1107-1116

  Witt, Stephan N ^a   Flower, Todd R ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

synuclein; Apoptosis; Glutathione; Methylglyoxal; ROS; Saccharomyces cerevisiae

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA SYNUCLEIN; BETA SYNUCLEIN; BIOLOGICAL MARKER; CATALASE; CYTOCHROME C; CYTOCHROME C OXIDASE; DNA FRAGMENT; DOPAMINE; GAMMA SYNUCLEIN; GLUTAREDOXIN; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; HYDROXYACYLGLUTATHIONE HYDROLASE; LACTOYLGLUTATHIONE LYASE; LIPID; MESSENGER RNA; PEROXIDASE; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

APOPTOSIS; CELL VACUOLE; DROSOPHILA; ENZYME RELEASE; EUKARYOTE; LYSOSOME; MODEL; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; RISK FACTOR; SACCHAROMYCES CEREVISIAE; SHORT SURVEY; WORM; YEAST CELL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALPHA-SYNUCLEIN; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASES; DOPAMINE; ELECTRON TRANSPORT COMPLEX I; HSP72 HEAT-SHOCK PROTEINS; HUMANS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; SACCHAROMYCES CEREVISIAE;

EUKARYOTA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 33751372793     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2006.00135.x     Document Type: Short Survey

References (63)

1. Auluck PK & Bonini NM (2002) Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 8: 1185-1186.
2. Auluck PK, Chan HY, Trojanowski JQ, Lee VM & Bonini NM (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295: 865-868.
3. Auluck PK, Meulener MC & Bonini NM (2005) Mechanisms of suppression of alpha-synuclein neurotoxicity by geldanamycin in Drosophila. J Biol Chem 280: 2873-2878.
4. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ & Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879-884.
5. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM & Green DR. (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2: 469-475.
6. Betarbet R, Sherer TB & Greenamyre JT (2005) Ubiquitin-proteasome system and Parkinson's diseases. Exp Neurol 191: S17-S27.
7. Bito A, Haider M, Hadler I & Breitenbach M (1997) Identification and phenotypic analysis of two glyoxalase II encoding genes from Saccharomyces cerevisiae, GLO2 and GLO4, and intracellular localization of the corresponding proteins. J Biol Chem 272: 21509-21519.
8. Caughey B & Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26: 267-298.
9. Conway KA, Rochet JC, Bieganski RM & Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294: 1346-1349.
10. Dawson TM & Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822.
11. Dedmon MM, Christodoulou J, Wilson MR & Dobson CM (2005) Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem 280: 14733-14740.
12. Ding TT, Lee SJ, Rochet JC & Lansbury PT Jr (2002) Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41: 10209-10217.
13. Dixon C, Mathias N, Zweig RM, Davis DA & Gross DS (2005) alpha-Synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast. Genetics 170: 47-59.
14. Elkon H, Don J, Melamed E, Ziv I, Shirvan A & Offen D (2002) Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome c oxidase. J Mol Neurosci 18: 229-238.
15. Fannjiang Y, Cheng WC, Lee SJ, Qi B, Pevsner J, McCaffery JM, Hill RB, Basanez G & Hardwick JM (2004) Mitochondrial fission proteins regulate programmed cell death in yeast. Genes Dev 18: 2785-2797.
16. Flower TR, Chesnokova LS, Froelich CA, Dixon C & Witt SN (2005) Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol 351: 1081-1100.
17. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K & Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4: 160-164.
18. Garrido C, Schmitt E, Cande C, Vahsen N, Parcellier A & Kroemer G (2003) HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle 2: 579-584.
19. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ & Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989.
20. Granot D, Levine A & Dor-Hefetz E (2003) Sugar-induced apoptosis in yeast cells. FEMS Yeast Res 4: 7-13.
21. Griffioen G, Duhamel H, Van Damme N, Pellens K, Zabrocki P, Pannecouque C, van Leuven F, Winderickx J & Wera S (2006) A yeast-based model of alpha-synucleinopathy identifies compounds with therapeutic potential. Biochim Biophys Acta 1762: 312-318.
22. Herker E, Jungwirth H, Lehmann KA, Maldener C, Frohlich KU, Wissing S, Buttner S, Fehr M, Sigrist S & Madeo F (2004) Chronological aging leads to apoptosis in yeast. J Cell Biol 164: 501-507.
23. Jenco JM, Rawlingson A, Daniels B & Morris AJ (1998) Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry 37: 4901-4909.
24. Kampranis SC, Damianova R, Atallah M, Toby G, Kondi G, Tsichlis PN & Makris AM (2000) A novel plant glutathione S-transferase/peroxidase suppresses Bax lethality in yeast. J Biol Chem 275: 29207-29216.
25. Kim S, Jeon BS, Heo C et al. (2004) Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease. FASEB J 18: 1615-1617.
26. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L & Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
27. Langston JW, Ballard P, Tetrud JW & Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980.
28. Levine A, Belenghi B, Damari-Weisler H & Granot D (2001) Vesicle-associated membrane protein of Arabidopsis suppresses Bax-induced apoptosis in yeast downstream of oxidative burst. J Biol Chem 276: 46284-46289.
29. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA & Robinson JP (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516-8525.
30. Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB & Jensen PH (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279: 12924-12934.
31. Liu CW, Giasson BI, Lewis KA, Lee VM, Demartino GN & Thomas PJ (2005) A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem 280: 22670-22678.
32. Lucking CB & Brice A (2000) Alpha-synuclein and Parkinson's disease. Cell Mol Life Sci 57: 1894-1908.
33. Ludovico P, Rodrigues F, Almeida A, Silva MT, Barrientos A & Côrte-Real M (2002) Cytochrome c release and mitochondria involvement in programmed cell death induced by acetic acid in Saccharomyces cerevisiae. Mol Biol Cell 13: 2598-2606.
34. Madeo F, Fröhlich E, Ligr M, Grey M, Sigrist SJ, Wolf DH & Fröhlich KU (1999) Oxygen stress: a regulator of apoptosis in yeast. J Cell Biol 145: 757-767.
35. Madeo F, Herker E, Maldener C et al. (2002) A caspase-related protease regulates apoptosis in yeast. Mol Cell 9: 911-917.
36. Madeo F, Herker E, Wissing S, Jungwirth H, Eisenberg T & Fröhlich KU (2004) Apoptosis in yeast. Curr Opin Microbiol 7: 655-660.
37. Maguire-Zeiss KA, Short DW & Federoff HJ (2005) Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Res Mol Brain Res 134: 18-23.
38. Munch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R & Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts - an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20: 253-257.
39. Narayanan V & Scarlata S (2001) Membrane binding and self-association of alpha-synucleins. Biochemistry 40: 9927-9934.
40. Outeiro TF & Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302: 1772-1775.
41. Polymeropoulos MH, Lavedan C, Leroy E et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
42. Rampello L, Cerasa S, Alvano A, Butta V, Raffaele R, Vecchio I, Cavallaro T, Cimino E, Incognito T & Nicoletti F (2004) Dementia with Lewy bodies: a review. Arch Gerontol Geriatr 39: 1-14.
43. Rochet JC, Outeiro TF, Conway KA, Ding TT, Volles MJ, Lashuel HA, Bieganski RM, Lindquist SL & Lansbury PT (2004) Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease. J Mol Neurosci 23: 23-34.
44. Saha AR, Ninkina NN, Hanger DP, Anderton BH, Davies AM & Buchman VL (2000) Induction of neuronal death by alpha-synuclein. Eur J Neurosci 12: 3073-3077.
45. Saleh A, Srinivasula SM, Balkir L, Robbins PD & Alnemri ES (2000) Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2: 476-483.
46. Schagger H (2002) Respiratory chain supercomplexes of mitochondria and bacteria. Biochim Biophys Acta 1555: 154-159.
47. Scherzer CR & Feany MB (2004) Yeast genetics targets lipids in Parkinson's disease. Trends Genet 20: 273-277.
48. Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR & Greenamyre JT (2002) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 22: 7006-7015.
49. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A & Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23: 10756-10764.
50. Slepenkov SV & Witt SN (2002) The unfolding story of the Escherichia coli Hsp70 DnaK: is DnaK a holdase or an unfoldase? Mol Microbiol 45: 1197-1206.
51. Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A, Dawson VL, Dawson TM & Ross CA (2005) Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 14: 3801-3811.
52. Souza JM, Giasson BI, Chen Q, Lee VM & Ischiropoulos H (2000) Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 275: 18344-18349.
53. Stefanova N, Klimaschewski L, Poewe W, Wenning GK & Reindl M (2001) Glial cell death induced by overexpression of alpha-synuclein. J Neurosci Res 65: 432-438.
54. Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, Dawson VL, Dawson TM & Ross CA (2001) Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 10: 919-926.
55. Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y &Allsop D (2001) alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radical Biol Med 30: 1163-1170.
56. van Heusden GPH & Steensma HY (2006) Yeast 14-3-3 proteins. Yeast 23: 159-171.
57. Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M & Przedborski S (2000) Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem 74: 721-729.
58. Wenning GK & Jellinger KA (2005) The role of alpha-synuclein in the pathogenesis of multiple system atrophy. Acta Neuropathol (Berlin) 109: 129-140.
59. Wheeler GL & Grant CM (2004) Regulation of redox homeostasis in the yeast Saccharomyces cerevisiae. Physiol Plant 120: 12-20.
60. Willingham S, Outeiro TF, DeVit MJ, Lindquist SL & Muchowski PJ (2003) Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302: 1769-1772.
61. Wissing S, Ludovico P, Herker E et al. (2004) An AIF orthologue regulates apoptosis in yeast. J Cell Biol 166: 969-974.
62. Xu J, Kao SY, Lee FJ, Song W, Jin LW & Yankner BA (2002) Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med 8: 600-606.
63. Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH & Zhang J (2004) Analysis of alpha-synuclein-associated proteins by quantitative proteomics. J Biol Chem 279: 39155-39164.